Recently, evidence has emerged for a connection between the genetic and pharmacological inhibition of cholesterol biosynthesis and TGF-β-mediated signaling pathways in the context of cancer stem cell maintenance and cancer progression to metastasis [19, 28, 36]. This evidence concerns the gene TGFB1 and cancer.